Search by Drug Name or NDC

NDC 70710-1049-03 Abacavir and lamivudine 600; 300 mg/1; mg/1 Details

Abacavir and lamivudine 600; 300 mg/1; mg/1

Abacavir and lamivudine is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is ABACAVIR SULFATE; LAMIVUDINE.

MedlinePlus Drug Summary

Abacavir is used along with other medications to treat human immunodeficiency virus (HIV) infection. Abacavir is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). It works by decreasing the amount of HIV in the blood. Although abacavir does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Taking these medications along with practicing safer sex and making other lifestyle changes may decrease the risk of transmitting (spreading) the HIV virus to other people.

Related Packages: 70710-1049-03
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Abacavir

Lamivudine (Epivir) is used along with other medications to treat human immunodeficiency virus (HIV) infection in adults and children 3 months of age and older. Lamivudine (Epivir-HBV) is used to treat hepatitis B infection. Lamivudine is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). It works by decreasing the amount of HIV and hepatitis B in the blood. Although lamivudine does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Taking these medications along with practicing safer sex and making other lifestyle changes may decrease the risk of transmitting (spreading) the HIV or hepatitis B virus to other people.

Related Packages: 70710-1049-03
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Lamivudine

Product Information

NDC	70710-1049
Product ID	70710-1049_35bd1a78-3b48-4df3-ac63-6f5f14816922
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Abacavir and lamivudine
Proprietary Name Suffix	n/a
Non-Proprietary Name	Abacavir and lamivudine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	600; 300
Active Ingredient Units	mg/1; mg/1
Substance Name	ABACAVIR SULFATE; LAMIVUDINE
Labeler Name	Zydus Pharmaceuticals USA Inc.
Pharmaceutical Class	Cytochrome P450 1A1 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse T
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA208990
Listing Certified Through	2024-12-31

Package

NDC 70710-1049-03 (70710104903)

Pricing Information	N/A
NDC Package Code	70710-1049-3
Billing NDC	70710104903
Package	30 TABLET, FILM COATED in 1 BOTTLE (70710-1049-3)
Marketing Start Date	2019-03-14
NDC Exclude Flag	N